Colin Drummond of Case Western Reserve University’s department of biomedical engineering discussed a few of the most promising medical technology spinoff companies from the university.
As director of the Coulter-Case Translational Research Partnership, Drummond is behind a $1 million fund that often invests in technologies spun out of Case.
Drummond discusses a few spinoff companies, including next-generation insulin developer Thermalin Diabetes and stroke device start Swallowing Solutions.

Comments
Post a comment
Don’t forget LifeServe! Rick Arlow et al
Comment by Marc Canter — October 5, 2011 @ 10:18 am
Post a Comment